Alpha-1 antitrypsin (A1AT)
Description of 22 new alpha-1 antitrypsin genetic variants
7
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
12
Alpha-1 Antitrypsin Deficiency A future NBS candidate?
17
COPD in individuals with the PiMZ alpha-1 antitrypsin genotype
10
The prevalence of alpha-1 antitrypsin deficiency in Ireland
7
A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha 1 antitrypsin deficiency and non alpha 1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma
8
Expression of the alpha 1 antitrypsin gene in mononuclear phagocytes of normal and alpha 1 antitrypsin deficient individuals
11
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
14
Z type alpha 1 antitrypsin is less competent than M1 type alpha 1 antitrypsin as an inhibitor of neutrophil elastase
10
Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
5
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
12
Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?
9
Diagnosis of alpha-1 antitrypsin deficiency: a population-based study
6
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
9
Hereditary alpha-1-antitrypsin deficiency and its clinical consequences
9
Alpha -1-antitrypsin deficiency, associated diseases and treatments: a review
7
Mechanism of Inhibition of Porcine Elastase by Human Alpha 1 Antitrypsin
11
The prevalence of alpha 1 antitrypsin deficiency in Ireland
7
Interrelationships between the Human Alveolar Macrophage and Alpha 1 Antitrypsin
8
Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review
14